INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q2 2023$1,548,708
+29.3%
93,975
-28.2%
0.80%
+24.8%
Q1 2023$1,198,183
+21.0%
130,806
-5.4%
0.64%
+24.0%
Q4 2022$990,271
+40.7%
138,306
-1.6%
0.52%
+42.1%
Q3 2022$704,000
+106.5%
140,575
+0.5%
0.36%
+105.1%
Q2 2022$341,000
-46.6%
139,875
+49.8%
0.18%
-45.0%
Q1 2022$638,000
-8.9%
93,375
+7.7%
0.32%
-3.3%
Q4 2021$700,000
+1.6%
86,675
+23.3%
0.33%
-7.0%
Q3 2021$689,000
+63.3%
70,275
+11.9%
0.36%
+57.7%
Q2 2021$422,000
-16.1%
62,775
+12.9%
0.23%
-22.3%
Q1 2021$503,000
+87.0%
55,625
+4.3%
0.29%
+62.2%
Q3 2020$269,000
-7.9%
53,325
+47.3%
0.18%
-11.3%
Q2 2020$292,000
+12.7%
36,200
+11.0%
0.20%
-4.2%
Q1 2020$259,000
-5.1%
32,600
-9.7%
0.21%
+27.7%
Q4 2019$273,000
+82.0%
36,1000.0%0.17%
+72.9%
Q3 2019$150,000
+56.2%
36,100
+9.1%
0.10%
+47.7%
Q2 2019$96,000
+92.0%
33,100
-4.7%
0.06%
+85.7%
Q1 2019$50,000
-43.2%
34,750
+1.5%
0.04%
-51.4%
Q4 2018$88,000
-38.0%
34,250
+6.2%
0.07%
-27.3%
Q3 2018$142,000
-1.4%
32,250
+37.5%
0.10%
-5.7%
Q2 2018$144,000
+30.9%
23,450
+55.8%
0.10%
+29.6%
Q1 2018$110,000
+29.4%
15,050
+45.4%
0.08%
+35.0%
Q4 2017$85,000
-26.7%
10,350
-6.3%
0.06%
-29.4%
Q3 2017$116,000
-4.9%
11,0500.0%0.08%
+1.2%
Q2 2017$122,000
+14.0%
11,0500.0%0.08%
+121.1%
Q1 2017$107,00011,0500.04%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 985,210$10,345,0006.10%
Broadfin Capital, LLC 3,568,122$37,465,0005.54%
JW Asset Management, LLC 444,439$4,667,0003.42%
ARMISTICE CAPITAL, LLC 1,688,000$17,724,0002.09%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,655,494$38,383,0001.73%
FALCON POINT CAPITAL, LLC 661,490$6,284,0000.91%
KNOTT DAVID M 158,555$1,665,0000.71%
Perceptive Advisors 3,098,010$32,530,0000.62%
Sio Capital Management, LLC 91,413$960,0000.50%
HEARTLAND ADVISORS INC 700,000$7,350,0000.48%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders